Industry Research Reports
Global Personalized Medicines Market Research Report 2025
Industry: Service & Software
Published Date: 2025-02-27
Pages: 96 Pages
Report ld: 4323115
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Personalized Medicines Market Size(US$)
CAGR 2025-2031
10.9%
Market Size,2031
USD 650,760
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 350,760 million
Market Forecast in 2031(Value)
US$ 650,760 million
CAGR
10.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Personalized Medicines was valued at US$ 319550 million in the year 2024 and is projected to reach a revised size of US$ 650760 million by 2031, growing at a CAGR of 10.9% during the forecast period.
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines.
The Personalized Medicines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- 3G Biotech
- Quest Diagnostics
- Laboratory Corporation of America
- Abbott
- Agendia NV
- Asuragen Inc
- Becton Dickinson
- CardioDx Inc.
- Foundation Medicine
- Qiagen
- Siemens Healthcare
- Amgen
- Bristol-Myers Squibb
- GE Healthcare
- Pfizer
- Sanofi
- 23andMe
- Illumina
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- PM Diagnostics
- PM Therapeutics
- Personalized Medical Care
- Personalized Nutrition & Wellness
Segment by Application
- Hospitals Pharmacies
- Retail Pharmacies
- Dietary Care Centers
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Medicines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines Market Perspective (2020-2031)
2.2 Global Personalized Medicines Growth Trends by Region
2.2.1 Global Personalized Medicines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Medicines Historic Market Size by Region (2020-2025)
2.2.3 Personalized Medicines Forecasted Market Size by Region (2026-2031)
2.3 Personalized Medicines Market Dynamics
2.3.1 Personalized Medicines Industry Trends
2.3.2 Personalized Medicines Market Drivers
2.3.3 Personalized Medicines Market Challenges
2.3.4 Personalized Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines Players by Revenue
3.1.1 Global Top Personalized Medicines Players by Revenue (2020-2025)
3.1.2 Global Personalized Medicines Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Medicines Revenue
3.4 Global Personalized Medicines Market Concentration Ratio
3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2024
3.5 Global Key Players of Personalized Medicines Head office and Area Served
3.6 Global Key Players of Personalized Medicines, Product and Application
3.7 Global Key Players of Personalized Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines Breakdown Data by Type
4.1 Global Personalized Medicines Historic Market Size by Type (2020-2025)
4.2 Global Personalized Medicines Forecasted Market Size by Type (2026-2031)
5 Personalized Medicines Breakdown Data by Application
5.1 Global Personalized Medicines Historic Market Size by Application (2020-2025)
5.2 Global Personalized Medicines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Medicines Market Size (2020-2031)
6.2 North America Personalized Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Medicines Market Size by Country (2020-2025)
6.4 North America Personalized Medicines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines Market Size (2020-2031)
7.2 Europe Personalized Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Medicines Market Size by Country (2020-2025)
7.4 Europe Personalized Medicines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines Market Size (2020-2031)
8.2 Asia-Pacific Personalized Medicines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Medicines Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Medicines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines Market Size (2020-2031)
9.2 Latin America Personalized Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Medicines Market Size by Country (2020-2025)
9.4 Latin America Personalized Medicines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines Market Size (2020-2031)
10.2 Middle East & Africa Personalized Medicines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Medicines Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Medicines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3G Biotech
11.1.1 3G Biotech Company Details
11.1.2 3G Biotech Business Overview
11.1.3 3G Biotech Personalized Medicines Introduction
11.1.4 3G Biotech Revenue in Personalized Medicines Business (2020-2025)
11.1.5 3G Biotech Recent Development
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Personalized Medicines Introduction
11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2020-2025)
11.2.5 Quest Diagnostics Recent Development
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Company Details
11.3.2 Laboratory Corporation of America Business Overview
11.3.3 Laboratory Corporation of America Personalized Medicines Introduction
11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2020-2025)
11.3.5 Laboratory Corporation of America Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Personalized Medicines Introduction
11.4.4 Abbott Revenue in Personalized Medicines Business (2020-2025)
11.4.5 Abbott Recent Development
11.5 Agendia NV
11.5.1 Agendia NV Company Details
11.5.2 Agendia NV Business Overview
11.5.3 Agendia NV Personalized Medicines Introduction
11.5.4 Agendia NV Revenue in Personalized Medicines Business (2020-2025)
11.5.5 Agendia NV Recent Development
11.6 Asuragen Inc
11.6.1 Asuragen Inc Company Details
11.6.2 Asuragen Inc Business Overview
11.6.3 Asuragen Inc Personalized Medicines Introduction
11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2020-2025)
11.6.5 Asuragen Inc Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Personalized Medicines Introduction
11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2020-2025)
11.7.5 Becton Dickinson Recent Development
11.8 CardioDx Inc.
11.8.1 CardioDx Inc. Company Details
11.8.2 CardioDx Inc. Business Overview
11.8.3 CardioDx Inc. Personalized Medicines Introduction
11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2020-2025)
11.8.5 CardioDx Inc. Recent Development
11.9 Foundation Medicine
11.9.1 Foundation Medicine Company Details
11.9.2 Foundation Medicine Business Overview
11.9.3 Foundation Medicine Personalized Medicines Introduction
11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2020-2025)
11.9.5 Foundation Medicine Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Personalized Medicines Introduction
11.10.4 Qiagen Revenue in Personalized Medicines Business (2020-2025)
11.10.5 Qiagen Recent Development
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Personalized Medicines Introduction
11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2020-2025)
11.11.5 Siemens Healthcare Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Personalized Medicines Introduction
11.12.4 Amgen Revenue in Personalized Medicines Business (2020-2025)
11.12.5 Amgen Recent Development
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2020-2025)
11.13.5 Bristol-Myers Squibb Recent Development
11.14 GE Healthcare
11.14.1 GE Healthcare Company Details
11.14.2 GE Healthcare Business Overview
11.14.3 GE Healthcare Personalized Medicines Introduction
11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2020-2025)
11.14.5 GE Healthcare Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Personalized Medicines Introduction
11.15.4 Pfizer Revenue in Personalized Medicines Business (2020-2025)
11.15.5 Pfizer Recent Development
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Personalized Medicines Introduction
11.16.4 Sanofi Revenue in Personalized Medicines Business (2020-2025)
11.16.5 Sanofi Recent Development
11.17 23andMe
11.17.1 23andMe Company Details
11.17.2 23andMe Business Overview
11.17.3 23andMe Personalized Medicines Introduction
11.17.4 23andMe Revenue in Personalized Medicines Business (2020-2025)
11.17.5 23andMe Recent Development
11.18 Illumina
11.18.1 Illumina Company Details
11.18.2 Illumina Business Overview
11.18.3 Illumina Personalized Medicines Introduction
11.18.4 Illumina Revenue in Personalized Medicines Business (2020-2025)
11.18.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Personalized Medicines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PM Diagnostics
Table 3. Key Players of PM Therapeutics
Table 4. Key Players of Personalized Medical Care
Table 5. Key Players of Personalized Nutrition & Wellness
Table 6. Global Personalized Medicines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Personalized Medicines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Personalized Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Personalized Medicines Market Share by Region (2020-2025)
Table 10. Global Personalized Medicines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Personalized Medicines Market Share by Region (2026-2031)
Table 12. Personalized Medicines Market Trends
Table 13. Personalized Medicines Market Drivers
Table 14. Personalized Medicines Market Challenges
Table 15. Personalized Medicines Market Restraints
Table 16. Global Personalized Medicines Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Personalized Medicines Market Share by Players (2020-2025)
Table 18. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2024)
Table 19. Ranking of Global Top Personalized Medicines Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Personalized Medicines Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Personalized Medicines, Headquarters and Area Served
Table 22. Global Key Players of Personalized Medicines, Product and Application
Table 23. Global Key Players of Personalized Medicines, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Personalized Medicines Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Personalized Medicines Revenue Market Share by Type (2020-2025)
Table 27. Global Personalized Medicines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Personalized Medicines Revenue Market Share by Type (2026-2031)
Table 29. Global Personalized Medicines Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Personalized Medicines Revenue Market Share by Application (2020-2025)
Table 31. Global Personalized Medicines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Personalized Medicines Revenue Market Share by Application (2026-2031)
Table 33. North America Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Personalized Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Personalized Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Personalized Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Personalized Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Personalized Medicines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Personalized Medicines Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Personalized Medicines Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Personalized Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Personalized Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Personalized Medicines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Personalized Medicines Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Personalized Medicines Market Size by Country (2026-2031) & (US$ Million)
Table 48. 3G Biotech Company Details
Table 49. 3G Biotech Business Overview
Table 50. 3G Biotech Personalized Medicines Product
Table 51. 3G Biotech Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 52. 3G Biotech Recent Development
Table 53. Quest Diagnostics Company Details
Table 54. Quest Diagnostics Business Overview
Table 55. Quest Diagnostics Personalized Medicines Product
Table 56. Quest Diagnostics Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 57. Quest Diagnostics Recent Development
Table 58. Laboratory Corporation of America Company Details
Table 59. Laboratory Corporation of America Business Overview
Table 60. Laboratory Corporation of America Personalized Medicines Product
Table 61. Laboratory Corporation of America Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 62. Laboratory Corporation of America Recent Development
Table 63. Abbott Company Details
Table 64. Abbott Business Overview
Table 65. Abbott Personalized Medicines Product
Table 66. Abbott Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Agendia NV Company Details
Table 69. Agendia NV Business Overview
Table 70. Agendia NV Personalized Medicines Product
Table 71. Agendia NV Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 72. Agendia NV Recent Development
Table 73. Asuragen Inc Company Details
Table 74. Asuragen Inc Business Overview
Table 75. Asuragen Inc Personalized Medicines Product
Table 76. Asuragen Inc Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 77. Asuragen Inc Recent Development
Table 78. Becton Dickinson Company Details
Table 79. Becton Dickinson Business Overview
Table 80. Becton Dickinson Personalized Medicines Product
Table 81. Becton Dickinson Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 82. Becton Dickinson Recent Development
Table 83. CardioDx Inc. Company Details
Table 84. CardioDx Inc. Business Overview
Table 85. CardioDx Inc. Personalized Medicines Product
Table 86. CardioDx Inc. Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 87. CardioDx Inc. Recent Development
Table 88. Foundation Medicine Company Details
Table 89. Foundation Medicine Business Overview
Table 90. Foundation Medicine Personalized Medicines Product
Table 91. Foundation Medicine Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 92. Foundation Medicine Recent Development
Table 93. Qiagen Company Details
Table 94. Qiagen Business Overview
Table 95. Qiagen Personalized Medicines Product
Table 96. Qiagen Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 97. Qiagen Recent Development
Table 98. Siemens Healthcare Company Details
Table 99. Siemens Healthcare Business Overview
Table 100. Siemens Healthcare Personalized Medicines Product
Table 101. Siemens Healthcare Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 102. Siemens Healthcare Recent Development
Table 103. Amgen Company Details
Table 104. Amgen Business Overview
Table 105. Amgen Personalized Medicines Product
Table 106. Amgen Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 107. Amgen Recent Development
Table 108. Bristol-Myers Squibb Company Details
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Personalized Medicines Product
Table 111. Bristol-Myers Squibb Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 112. Bristol-Myers Squibb Recent Development
Table 113. GE Healthcare Company Details
Table 114. GE Healthcare Business Overview
Table 115. GE Healthcare Personalized Medicines Product
Table 116. GE Healthcare Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 117. GE Healthcare Recent Development
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Personalized Medicines Product
Table 121. Pfizer Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 122. Pfizer Recent Development
Table 123. Sanofi Company Details
Table 124. Sanofi Business Overview
Table 125. Sanofi Personalized Medicines Product
Table 126. Sanofi Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 127. Sanofi Recent Development
Table 128. 23andMe Company Details
Table 129. 23andMe Business Overview
Table 130. 23andMe Personalized Medicines Product
Table 131. 23andMe Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 132. 23andMe Recent Development
Table 133. Illumina Company Details
Table 134. Illumina Business Overview
Table 135. Illumina Personalized Medicines Product
Table 136. Illumina Revenue in Personalized Medicines Business (2020-2025) & (US$ Million)
Table 137. Illumina Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Personalized Medicines Picture
Figure 2. Global Personalized Medicines Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Medicines Market Share by Type: 2024 VS 2031
Figure 4. PM Diagnostics Features
Figure 5. PM Therapeutics Features
Figure 6. Personalized Medical Care Features
Figure 7. Personalized Nutrition & Wellness Features
Figure 8. Global Personalized Medicines Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Personalized Medicines Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Dietary Care Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Medicines Report Years Considered
Figure 15. Global Personalized Medicines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Personalized Medicines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Personalized Medicines Market Share by Region: 2024 VS 2031
Figure 18. Global Personalized Medicines Market Share by Players in 2024
Figure 19. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Personalized Medicines Revenue in 2024
Figure 21. North America Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Personalized Medicines Market Share by Country (2020-2031)
Figure 23. United States Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Personalized Medicines Market Share by Country (2020-2031)
Figure 27. Germany Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicines Market Share by Region (2020-2031)
Figure 35. China Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Personalized Medicines Market Share by Country (2020-2031)
Figure 43. Mexico Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Personalized Medicines Market Share by Country (2020-2031)
Figure 47. Turkey Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Personalized Medicines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. 3G Biotech Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 51. Quest Diagnostics Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 52. Laboratory Corporation of America Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 53. Abbott Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 54. Agendia NV Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 55. Asuragen Inc Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 56. Becton Dickinson Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 57. CardioDx Inc. Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 58. Foundation Medicine Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 59. Qiagen Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 60. Siemens Healthcare Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 61. Amgen Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 63. GE Healthcare Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 64. Pfizer Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 65. Sanofi Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 66. 23andMe Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 67. Illumina Revenue Growth Rate in Personalized Medicines Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Personalized Medicines market?
The top companies in the global Personalized Medicines market are 3G Biotech、Quest Diagnostics、Laboratory Corporation of America.
What is the annual compound growth rate of the global Personalized Medicines market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Personalized Medicines in 2025?
What was the global market size of Personalized Medicines in 2031?
Related Reports
Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Medicines was estimated to be worth US$ 350760 million in 2025 and is projected to reach US$ 714300 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-07-15
Pages: 139
USD 3950.00
(Single User License)
Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published Date: 2026-04-28
Pages: 129
USD 2900.00
(Single User License)
Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 101
USD 4250.00
(Single User License)
Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 137
USD 3950.00
(Single User License)
Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-04-25
Pages: 117
USD 4900.00
(Single User License)
Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-01-24
Pages: 123
USD 3950.00
(Single User License)
Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published Date: 2024-01-11
Pages: 91
USD 2900.00
(Single User License)
Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Medicines was estimated to be worth US$ 350760 million in 2025 and is projected to reach US$ 714300 million, growing at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-07-15
Pages: 139
USD 3950.00 (Single User License)Global Personalized Medicines Market Research Report 2026
The global Personalized Medicines market was valued at US$ 350760 million in 2025 and is anticipated to reach US$ 714300 million by 2032, at a CAGR of 10.9% from 2026 to 2032.
Published: 2026-04-28
Pages: 129
USD 2900.00 (Single User License)Global Personalized Medicines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Medicines market size was US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 101
USD 4250.00 (Single User License)Personalized Medicines- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Personalized Medicines was estimated to be worth US$ 319550 million in 2024 and is forecast to a readjusted size of US$ 650760 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 137
USD 3950.00 (Single User License)Global Personalized Medicines Market Insights, Forecast to 2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-04-25
Pages: 117
USD 4900.00 (Single User License)Personalized Medicines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-01-24
Pages: 123
USD 3950.00 (Single User License)Global Personalized Medicines Market Research Report 2024
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Published: 2024-01-11
Pages: 91
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now